ד"ר אור פרלמן

סגל אקדמי בכיר במחלקה להנדסה ביו-רפואית
מחלקה להנדסה ביו-רפואית סגל אקדמי בכיר

Education

Postdoc - Dept. of Radiology, Harvard Medical School and Massachusetts General Hospital

PhD - Biomedical Engineering, Technion – Israel Institute of Technology

MSc (Cum Laude) - Biomedical Engineering, Ben Gurion University of the Negev, Israel

BSc (Cum Laude) - Biomedical Engineering, Ben Gurion University of the Negev, Israel

Keywords

Medical Imaging, MRI, AI, Machine Learning, Deep Learning, Cancer, Neurological Disorders, Neuroscience, Molecular Imaging

Selected Publications

O. Perlman, H. Ito, K. Herz, N. Shono, H. Nakashima, M. Zaiss, E. A. Chiocca, O. Cohen, M. S. Rosen, C. T. Farrar, ”Quantitative imaging of apoptosis following oncolytic virotherapy by magnetic resonance fingerprinting aided by deep learning,” Nature Biomedical Engineering, Vol. 6, pp. 648-657, 2022. https://www.nature.com/articles/s41551-021-00809-7

 

O. Perlman*, B. Zhu*, M. Zaiss, M. S. Rosen, C. T. Farrar, ”An End-to-End AI-Based Framework for Automated Discovery of Rapid CEST/MT MRI Acquisition Protocols and Molecular Parameter Quantification (AutoCEST),” Magnetic Resonance in Medicine, Vol. 87, pp. 2792-2810, 2022.
∗ Equal contribution. Highlighted by the journal - included in the Editor’s Pick List.
https://onlinelibrary.wiley.com/doi/10.1002/mrm.29173


O. Perlman, H. Ito, A. A. Gilad, M. T. McMahon, E. A. Chiocca, E. H. Nakashima, C. T. Farrar, ”Redesigned reporter gene for improved proton exchange-based molecular MRI contrast,” Scientific Reports, Vol. 10, 20664, 2020. https://www.nature.com/articles/s41598-020-77576-z
 

O. Perlman, A. Borodetsky, Y. Kauffmann, Y. Shamay, H. Azhar, I. S. Weitz, “Gold/copper@ polydopamine nanocomposite for contrast-enhanced dual modal computed tomography-magnetic resonance imaging,” ACS Applied Nano-Materials, Vol. 2, No. 10, pp. 6124-6134, 2019. https://pubs.acs.org/doi/abs/10.1021/acsanm.9b00791

 

 

Research Interest

Our lab explores the molecular mechanisms underlying brain disease and develops methods for early diagnosis and therapy optimization. We develop tools for disentangling the different signals coming from brain metabolites, proteins, and lipids, and evaluate their potential to serve as noninvasive image bio-markers for cell death, ischemia, and disease severity. We design and implement AI-based methods for early interventions along the imaging pipeline, enabling automatic MRI acquisition protocol discovery and quantitative molecular parameters reconstruction. This allows for a drastic reduction in scan time and compatibility with a variety of biological scenarios.

אוניברסיטת תל אביב עושה כל מאמץ לכבד זכויות יוצרים. אם בבעלותך זכויות יוצרים בתכנים שנמצאים פה ו/או השימוש
שנעשה בתכנים אלה לדעתך מפר זכויות, נא לפנות בהקדם לכתובת שכאן >>